Detalhe da pesquisa
1.
Immuno-Oncology in the Era of Personalized Medicine.
Adv Exp Med Biol
; 1168: 117-129, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31713168
2.
Polyfunctional anti-human epidermal growth factor receptor 3 (anti-HER3) antibodies induced by HER3 vaccines have multiple mechanisms of antitumor activity against therapy resistant and triple negative breast cancers.
Breast Cancer Res
; 20(1): 90, 2018 08 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30092835
3.
A signature of epithelial-mesenchymal plasticity and stromal activation in primary tumor modulates late recurrence in breast cancer independent of disease subtype.
Breast Cancer Res
; 16(4): 407, 2014 Jul 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-25060555
4.
An heregulin-EGFR-HER3 autocrine signaling axis can mediate acquired lapatinib resistance in HER2+ breast cancer models.
Breast Cancer Res
; 15(5): R85, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24044505
5.
Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 Trial.
J Clin Oncol
; 41(2): 198-205, 2023 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36332179
6.
Vaccine Therapies for Cancer: Then and Now.
Target Oncol
; 16(2): 121-152, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33512679
7.
Pembrolizumab with low-dose carboplatin for recurrent platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer: survival and immune correlates.
J Immunother Cancer
; 9(9)2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34531249
8.
Heat shock protein 90-targeted photodynamic therapy enables treatment of subcutaneous and visceral tumors.
Commun Biol
; 3(1): 226, 2020 05 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32385408
9.
CYP1A1 genetic polymorphism is a promising predictor to improve chemotherapy effects in patients with metastatic breast cancer treated with docetaxel plus thiotepa vs. docetaxel plus capecitabine.
Cancer Chemother Pharmacol
; 81(2): 365-372, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29242966
10.
In Vivo Detection of HSP90 Identifies Breast Cancers with Aggressive Behavior.
Clin Cancer Res
; 23(24): 7531-7542, 2017 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28993342
11.
Adaptive T cell responses induced by oncolytic Herpes Simplex Virus-granulocyte macrophage-colony-stimulating factor therapy expanded by dendritic cell and cytokine-induced killer cell adoptive therapy.
Oncoimmunology
; 6(4): e1264563, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28507788
12.
Vaccination targeting human HER3 alters the phenotype of infiltrating T cells and responses to immune checkpoint inhibition.
Oncoimmunology
; 6(6): e1315495, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28680745
13.
Dendritic Cell/Cytokine-Induced Killer Cell Immunotherapy Combined with S-1 in Patients with Advanced Pancreatic Cancer: A Prospective Study.
Clin Cancer Res
; 23(17): 5066-5073, 2017 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28611200
14.
Pertuzumab protects the achilles' heel of trastuzumab--emtansine.
Clin Cancer Res
; 20(2): 278-80, 2014 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24240115